Market Research Life Sciences Market Research Pharmaceuticals Market Research Manufacturing, Packaging & Detailing Market Research

The World Market for Medicaments Containing Hormones, Their Derivatives, and Other Steroids Used as Hormones: A 2024 Global Trade Perspective

Best Price Guarantee Length Publisher Published Date SKU
from $795 111 Pages Icon Group International, Inc. May, 2023 ICN17970284
Best Price Guarantee
Price from $795
Length 111 Pages
Publisher Icon Group International, Inc.
Published Date May, 2023
SKU ICN17970284

The World Market for Medicaments Containing Hormones, Their Derivatives, and Other Steroids Used as Hormones: A 2024 Global Trade Perspective


This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for medicaments containing hormones, their derivatives, and other steroids used as hormones excluding antibiotics and their derivatives. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for medicaments containing hormones, their derivatives, and other steroids used as hormones excluding antibiotics and their derivatives for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models.

"Medicaments containing hormones, their derivatives, and other steroids used as hormones excluding antibiotics and their derivatives" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines "medicaments containing hormones, their derivatives, and other steroids used as hormones excluding antibiotics and their derivatives" is 5422.


1 METHODOLOGY
1.1 OUR APPROACH
2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES EXPORT SUPPLIES IN 2024
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IN 2024
3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IN 2024
3.1.1 EXECUTIVE SUMMARY
3.1.2 BOTSWANA
3.1.3 BURKINA FASO
3.1.4 EGYPT
3.1.5 ERITREA
3.1.6 ESWATINI
3.1.7 GHANA
3.1.8 KENYA
3.1.9 MAURITANIA
3.1.10 MAURITIUS
3.1.11 MOROCCO
3.1.12 SOUTH AFRICA
3.1.13 TOGO
3.1.14 TUNISIA
3.1.15 UGANDA
3.1.16 ZAMBIA
3.2 ASIA: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IN 2024
3.2.1 EXECUTIVE SUMMARY
3.2.2 BANGLADESH
3.2.3 CHINA
3.2.4 HONG KONG
3.2.5 INDIA
3.2.6 INDONESIA
3.2.7 JAPAN
3.2.8 MALAYSIA
3.2.9 SINGAPORE
3.2.10 SOUTH KOREA
3.2.11 SRI LANKA
3.2.12 TAIWAN
3.2.13 THAILAND
3.2.14 THE PHILIPPINES
3.2.15 VIETNAM
3.3 EUROPE: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IN 2024
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELARUS
3.3.4 BELGIUM
3.3.5 BOSNIA AND HERZEGOVINA
3.3.6 BULGARIA
3.3.7 CROATIA
3.3.8 CYPRUS
3.3.9 DENMARK
3.3.10 ESTONIA
3.3.11 FINLAND
3.3.12 FRANCE
3.3.13 GEORGIA
3.3.14 GERMANY
3.3.15 GREECE
3.3.16 HUNGARY
3.3.17 ICELAND
3.3.18 IRELAND
3.3.19 ITALY
3.3.20 KAZAKHSTAN
3.3.21 LATVIA
3.3.22 LITHUANIA
3.3.23 LUXEMBOURG
3.3.24 MALTA
3.3.25 MOLDOVA
3.3.26 NORWAY
3.3.27 POLAND
3.3.28 PORTUGAL
3.3.29 ROMANIA
3.3.30 RUSSIA
3.3.31 SLOVAKIA
3.3.32 SLOVENIA
3.3.33 SPAIN
3.3.34 SWEDEN
3.3.35 SWITZERLAND
3.3.36 THE CZECH REPUBLIC
3.3.37 THE NETHERLANDS
3.3.38 THE UNITED KINGDOM
3.3.39 UKRAINE
3.4 LATIN AMERICA: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IN 2024
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BRAZIL
3.4.4 CHILE
3.4.5 COLOMBIA
3.4.6 COSTA RICA
3.4.7 ECUADOR
3.4.8 EL SALVADOR
3.4.9 GUATEMALA
3.4.10 HONDURAS
3.4.11 MEXICO
3.4.12 PANAMA
3.4.13 PARAGUAY
3.4.14 PERU
3.4.15 URUGUAY
3.4.16 VENEZUELA
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IN 2024
3.5.1 EXECUTIVE SUMMARY
3.5.2 BARBADOS
3.5.3 CANADA
3.5.4 CUBA
3.5.5 THE DOMINICAN REPUBLIC
3.5.6 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IN 2024
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.6.3 FIJI
3.6.4 NEW ZEALAND
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IN 2024
3.7.1 EXECUTIVE SUMMARY
3.7.2 ARMENIA
3.7.3 IRAN
3.7.4 ISRAEL
3.7.5 JORDAN
3.7.6 KUWAIT
3.7.7 OMAN
3.7.8 PAKISTAN
3.7.9 SAUDI ARABIA
3.7.10 SYRIA
3.7.11 THE UNITED ARAB EMIRATES
3.7.12 TURKEY
4 IMPORTS
4.1 AFRICA: MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IMPORTS IN 2024
4.1.1 EXECUTIVE SUMMARY
4.1.2 ALGERIA
4.1.3 BENIN
4.1.4 BOTSWANA
4.1.5 BURKINA FASO
4.1.6 BURUNDI
4.1.7 CAMEROON
4.1.8 CAPE VERDE
4.1.9 COTE D'IVOIRE
4.1.10 EGYPT
4.1.11 ETHIOPIA
4.1.12 GUINEA
4.1.13 MADAGASCAR
4.1.14 MALAWI
4.1.15 MAURITANIA
4.1.16 MAURITIUS
4.1.17 MOROCCO
4.1.18 MOZAMBIQUE
4.1.19 NAMIBIA
4.1.20 NIGER
4.1.21 NIGERIA
4.1.22 RWANDA
4.1.23 SENEGAL
4.1.24 SIERRA LEONE
4.1.25 SOUTH AFRICA
4.1.26 TANZANIA
4.1.27 THE CENTRAL AFRICAN REPUBLIC
4.1.28 THE DEMOCRATIC REPUBLIC OF THE CONGO
4.1.29 UGANDA
4.1.30 ZAMBIA
4.1.31 ZIMBABWE
4.2 ASIA: MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IMPORTS IN 2024
4.2.1 EXECUTIVE SUMMARY
4.2.2 BRUNEI
4.2.3 CHINA
4.2.4 HONG KONG
4.2.5 INDIA
4.2.6 INDONESIA
4.2.7 JAPAN
4.2.8 MACAU
4.2.9 MALAYSIA
4.2.10 MONGOLIA
4.2.11 NEPAL
4.2.12 SINGAPORE
4.2.13 SOUTH KOREA
4.2.14 SRI LANKA
4.2.15 TAIWAN
4.2.16 THAILAND
4.2.17 THE MALDIVES
4.2.18 THE PHILIPPINES
4.2.19 VIETNAM
4.3 EUROPE: MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IMPORTS IN 2024
4.3.1 EXECUTIVE SUMMARY
4.3.2 ALBANIA
4.3.3 ANDORRA
4.3.4 AUSTRIA
4.3.5 BELARUS
4.3.6 BELGIUM
4.3.7 BOSNIA AND HERZEGOVINA
4.3.8 BULGARIA
4.3.9 CROATIA
4.3.10 CYPRUS
4.3.11 DENMARK
4.3.12 ESTONIA
4.3.13 FINLAND
4.3.14 FRANCE
4.3.15 GEORGIA
4.3.16 GERMANY
4.3.17 GREECE
4.3.18 HUNGARY
4.3.19 ICELAND
4.3.20 IRELAND
4.3.21 ITALY
4.3.22 KAZAKHSTAN
4.3.23 LATVIA
4.3.24 LITHUANIA
4.3.25 LUXEMBOURG
4.3.26 MACEDONIA
4.3.27 MALTA
4.3.28 MOLDOVA
4.3.29 NORWAY
4.3.30 POLAND
4.3.31 PORTUGAL
4.3.32 ROMANIA
4.3.33 RUSSIA
4.3.34 SLOVAKIA
4.3.35 SLOVENIA
4.3.36 SPAIN
4.3.37 SWEDEN
4.3.38 SWITZERLAND
4.3.39 THE CZECH REPUBLIC
4.3.40 THE NETHERLANDS
4.3.41 THE UNITED KINGDOM
4.3.42 UKRAINE
4.4 LATIN AMERICA: MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IMPORTS IN 2024
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BELIZE
4.4.4 BOLIVIA
4.4.5 BRAZIL
4.4.6 CHILE
4.4.7 COLOMBIA
4.4.8 ECUADOR
4.4.9 EL SALVADOR
4.4.10 GUATEMALA
4.4.11 GUYANA
4.4.12 HONDURAS
4.4.13 MEXICO
4.4.14 NICARAGUA
4.4.15 PANAMA
4.4.16 PARAGUAY
4.4.17 PERU
4.4.18 SURINAME
4.4.19 URUGUAY
4.5 NORTH AMERICA & THE CARIBBEAN: MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IMPORTS IN 2024
4.5.1 EXECUTIVE SUMMARY
4.5.2 ANTIGUA AND BARBUDA
4.5.3 ARUBA
4.5.4 BARBADOS
4.5.5 BERMUDA
4.5.6 CANADA
4.5.7 JAMAICA
4.5.8 ST. LUCIA
4.5.9 THE BAHAMAS
4.5.10 THE DOMINICAN REPUBLIC
4.5.11 THE UNITED STATES
4.6 OCEANIA: MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IMPORTS IN 2024
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 FIJI
4.6.4 FRENCH POLYNESIA
4.6.5 NEW CALEDONIA
4.6.6 NEW ZEALAND
4.6.7 PALAU
4.6.8 TONGA
4.7 THE MIDDLE EAST: MEDICAMENTS CONTAINING HORMONES, THEIR DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING ANTIBIOTICS AND THEIR DERIVATIVES IMPORTS IN 2024
4.7.1 EXECUTIVE SUMMARY
4.7.2 ARMENIA
4.7.3 AZERBAIJAN
4.7.4 BAHRAIN
4.7.5 ISRAEL
4.7.6 JORDAN
4.7.7 KUWAIT
4.7.8 LEBANON
4.7.9 OMAN
4.7.10 PAKISTAN
4.7.11 QATAR
4.7.12 TURKEY
4.7.13 YEMEN
5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS

$795
$1,590

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings